What Fueled The Previous Growth In The Leukotriene Modifiers Market?
The leukotriene modifiers market has seen considerable growth due to a variety of factors.
• The leukotriene modifiers market has experienced strong growth in recent years. It will grow from $22.33 billion in 2024 to $23.77 billion in 2025, at a CAGR of 6.4%.
Growth is attributed to regulatory approvals, increased awareness among healthcare professionals and patients, the introduction of generic versions, expanded indications for leukotriene modifiers, and growing collaborations between pharmaceutical companies and healthcare providers.
What Can Be Expected from the Leukotriene Modifiers Market Size?
The leukotriene modifiers market is expected to maintain its strong growth trajectory in upcoming years.
• The leukotriene modifiers market is expected to reach $30.2 billion by 2029, growing at a CAGR of 6.2%.
This growth is attributed to the rise in healthcare infrastructure in emerging markets, a shift towards personalized medicine, the adoption of telemedicine, and ongoing R&D in drug candidates. Key trends include the use of mobile apps and wearables, AI and machine learning integration, novel therapeutic targets, patient engagement tools, and continuous drug production.
What Are the Critical Driver Fuelling The Leukotriene Modifiers Market's Growth?
The rising incidence of asthma and allergic conditions is expected to propel the leukotriene modifier market. Factors like pollution, changing climates, and population density are contributing to a rise in asthma and allergies. Leukotriene modifiers help manage these conditions by reducing inflammation and improving respiratory health. For instance, in May 2024, the National Center for Health Statistics reported an increase in asthma prevalence in the US, further driving demand for leukotriene modifiers.
How Is The Leukotriene Modifiers Market segmented?
The leukotriene modifiers market covered in this report is segmented –
1) By Drug Type: Montelukast, Zafirlukast, Zileuton ER, Zileuton
2) By Form: Tablets, Chewable Tablets, Oral Granules
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By Montelukast: Tablet Formulation, Chewable Tablet Formulation, Oral Granules
2) By Zafirlukast: Tablet Formulation
3) By Zileuton ER: Extended-Release Tablet Formulation
4) By Zileuton: Tablet Formulation, Oral Suspension Formulation
Pre-Book The Leukotriene Modifiers Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Leukotriene Modifiers Market?
Leading corporations in the leukotriene modifier market are concentrating on the creation of generic versions of drugs like extended-release (ER) tablets to widen their range and cater to the escalating need for fresher, effective therapies. Generic ER tablets are drug compositions meant to gradually dispense their active constituents over a prolonged duration, often offering ease of use and optimized dosage patterns in comparison to immediate-release versions. For instance, in April 2023, Zileuton ER Tablets were introduced to the market by Camber Pharmaceuticals Inc., a pharmaceutical firm based in the U.S. These tablets are used for prevention and long-term treatment of asthma in adults and children 12 years and above. These tablets shouldn't be used for immediate relief from acute asthma attacks, but can be used continuously during acute flare-ups of asthma. Zileuton ER Tablets come in a strength of 600 mg and are available in bottles of 120-count.
Who Are the Key Players In The Leukotriene Modifiers Market?
Major companies operating in the leukotriene modifiers market are:
• Merck And Co.
• Sanofi SA
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline plc
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Hetero Drugs Limited
• Sun Pharmaceutical Industries
• Sumitomo Dainippon Pharma
• Chiesi Farmaceutici S.p.A.
• Cipla Limited
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories
• Apotex Pharmaceutical Holdings Inc.
• Torrent Pharmaceuticals Ltd.
• DAVA Pharmaceuticals
• Alembic Pharmaceuticals Ltd.
• Starallergens Greer Ltd
• Lannett Company
• Accord Healthcare
• Jubilant Life Sciences Ltd.
• Aytu BioScience
• Annett Company Inc.
What Is The Most Dominant Region In The Leukotriene Modifiers Market?
North America was the largest region in the leukotriene modifiers market in 2023. The regions covered in the leukotriene modifiers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
